⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL251357 | 0.77 | MGMT (0.40) | — | |
| SCHEMBL4082360 | 0.77 | FBP1 (0.39) | — | |
| SCHEMBL30039658 | 0.76 | FBP1 (0.40) | — | |
| SCHEMBL10497238 | 0.76 | FBP1 (0.35) | — | |
| SCHEMBL9682640 | 0.74 | MGMT (0.39) | — | |
| SCHEMBL10638201 | 0.74 | — | — | |
| SCHEMBL266567 | 0.72 | — | — | |
| SCHEMBL181927 | 0.72 | — | — | |
| SCHEMBL247102 | 0.72 | — | — | |
| SCHEMBL73652 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240148777-A1 | METHODS AND COMPOSITIONS FOR TREATING CLOSTRIDIODES DIFFICILE INFECTIONS | MATRIVAX INC (US) | 2024-05-09 | — | — | US | disclosed |
| EP-4313065-A2 | METHODS AND COMPOSITIONS FOR TREATING CLOSTRIDIODES DIFFICILE INFECTIONS | Matrivax, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117460516-A | Methods and compositions for treating clostridium difficile infection | 马特里瓦克斯公司 | 2024-01-26 | — | — | CN | disclosed |
| US-20210401960-A1 | MULTIVALENT GLYCOCONJUGATES IMMUNOGENIC COMPOSITIONS | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2021-12-30 | — | — | US | disclosed |
| EP-3876981-A1 | MULTIVALENT GLYCOCONJUGATES IMMUNOGENIC COMPOSITIONS | Bharat Biotech International Limited (IN) | 2021-09-15 | — | — | EP | disclosed |
| CN-113271967-A | Multivalent glycoconjugate immunogenic compositions | 巴拉特生物技术国际有限公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-107748157-B | Respiration detection system based on chemically modified surface enhanced Raman scattering chip | 中国科学院微电子研究所 | 2020-08-04 | — | — | CN | disclosed |
| US-9144604-B2 | Vaccine for Shigella | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2015-09-29 | — | — | US | disclosed |
| US-20140378669-A1 | METHODS FOR CONJUGATION OF OLIGOSACCHARIDES OR POLYSACCHARIDES TO PROTEIN CARRIERS THROUGH OXIME LINKAGES VIA 3-DEOXY-D-MANNO-OCTULSONIC ACID | The U.S.A , as represented by the Secretary, Department of Health and Human Services (US) | 2014-12-25 | — | — | US | disclosed |
| US-20140242666-A1 | VACCINE FOR SHIGELLA | The United States of America, as represented by the Secretary, Department of Health and Human Ser (US) | 2014-08-28 | — | — | US | disclosed |
| US-8795680-B2 | Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2014-08-05 | — | — | US | disclosed |
| US-8747863-B2 | Vaccine for shigella | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2014-06-10 | — | — | US | disclosed |
| WO-2012106251-A2 | PERTUSSIS VACCINE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-08-09 | — | — | WO | disclosed |
| US-20110212125-A1 | VACCINE FOR SHIGELLA | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-09-01 | — | — | US | disclosed |
| US-20100158937-A1 | METHODS FOR CONJUGATION OF OLIGOSACCHARIDES OR POLYSACCHARIDES TO PROTEIN CARRIERS THROUGH OXIME LINKAGES VIA 3-DEOXY-D-MANNO-OCTULSONIC ACID | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE | 2010-06-24 | — | — | US | disclosed |
| WO-2010019890-A2 | VACCINE FOR SHIGELLA | THE GOVERNMENT OF THE USA, AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2008013735-A2 | METHODS FOR CONJUGATION OF OLIGOSACCHARIDES OR POLYSACCHARIDES TO PROTEIN CARRIERS THROUGH OXIME LINKAGES VIA 3-DEOXY-D-MANNO-OCTULSONIC ACID | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2008-01-31 | — | — | WO | disclosed |
| US-4647698-A | Novel compositions | SANDOZ LTD. (US) | 1987-03-03 | — | — | US | disclosed |